Bakken Trygve E, Bloss Cinnamon S, Roddey J Cooper, Joyner Alexander H, Rimol Lars M, Djurovic Srdjan, Melle Ingrid, Sundet Kjetil, Agartz Ingrid, Andreassen Ole A, Dale Anders M, Schork Nicholas J
The Scripps Research Institute, Scripps Translational Science Institute, 3344 N Torrey Pines Court, La Jolla, CA 92037, USA.
Arch Gen Psychiatry. 2011 Aug;68(8):781-90. doi: 10.1001/archgenpsychiatry.2011.81.
Cortical thickness is a highly heritable structural brain measurement, and reduced thickness has been associated with schizophrenia, bipolar disorder, and decreased cognitive performance among healthy control individuals. Identifying genes that contribute to variation in cortical thickness provides a means to elucidate some of the biological mechanisms underlying these diseases and general cognitive abilities.
To identify common genetic variants that affect cortical thickness in patients with schizophrenia, patients with bipolar disorder, and controls and to test these variants for association with cognitive performance.
A total of 597 198 single-nucleotide polymorphisms were tested for association with average cortical thickness in a genome-wide association study. Significantly associated single-nucleotide polymorphisms were tested for their effect on several measures of cognitive performance.
Four major hospitals in Oslo, Norway.
A total of 1054 case individuals and controls were analyzed in the genome-wide association study and follow-up cognitive study. The genome-wide association study included controls (n = 181) and individuals with DSM-IV -diagnosed schizophrenia spectrum disorder (n = 94), bipolar spectrum disorder (n = 97), and other psychotic and affective disorders (n = 49).
Cortical thickness measured with magnetic resonance imaging and cognitive performance as assessed by several neuropsychological tests.
Two closely linked genetic variants (rs4906844 and rs11633924) within the Prader-Willi and Angelman syndrome region on chromosome 15q12 showed a genome-wide significant association (P = 1.1 x 10(-8) with average cortical thickness and modest association with cognitive performance (permuted P = .03) specifically among patients diagnosed as having schizophrenia.
This genome-wide association study identifies a common genetic variant that contributes to the heritable reduction of cortical thickness in schizophrenia. These results highlight the usefulness of cortical thickness as an intermediate phenotype for neuropsychiatric diseases. Future independent replication studies are required to confirm these findings.
皮质厚度是一种具有高度遗传性的脑结构测量指标,皮质厚度降低与精神分裂症、双相情感障碍以及健康对照个体的认知能力下降有关。识别导致皮质厚度变异的基因有助于阐明这些疾病和一般认知能力背后的一些生物学机制。
识别影响精神分裂症患者、双相情感障碍患者和对照者皮质厚度的常见基因变异,并测试这些变异与认知表现的关联性。
在一项全基因组关联研究中,对总共597198个单核苷酸多态性与平均皮质厚度的关联性进行了测试。对显著相关的单核苷酸多态性对几种认知表现指标的影响进行了测试。
挪威奥斯陆的四家主要医院。
在全基因组关联研究和后续认知研究中,总共对1054例病例个体和对照者进行了分析。全基因组关联研究包括对照者(n = 181)以及被诊断为患有DSM-IV精神分裂症谱系障碍(n = 94)、双相谱系障碍(n = 97)和其他精神性及情感性障碍(n = 49)的个体。
通过磁共振成像测量的皮质厚度以及通过多项神经心理学测试评估的认知表现。
位于15号染色体q12上普拉德-威利综合征和安吉尔曼综合征区域内的两个紧密连锁的基因变异(rs4906844和rs11633924)显示出全基因组显著关联(与平均皮质厚度的P = 1.1×10⁻⁸),并且与认知表现有适度关联(置换P = 0.03),特别是在被诊断为精神分裂症的患者中。
这项全基因组关联研究识别出一种常见基因变异,该变异导致精神分裂症患者皮质厚度的遗传性降低。这些结果凸显了皮质厚度作为神经精神疾病中间表型的有用性。未来需要独立的重复研究来证实这些发现。